Related Experiment Video

Updated: Jun 23, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Convalescent Plasma and the Dose of Ebola Virus Antibodies

Thierry Burnouf1, John M Dye2, Akin Abayomi3

  • 1Taipei Medical University, Taipei, Taiwan thburnouf@gmail.com

The New England Journal of Medicine
|March 30, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum07:06

A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

Published on: April 10, 2018

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview